Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3206 participants.

Also called NCT01035450

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 3,206 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01035450
Other papers using this trial's data
  • 7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial JACC. Cardiovascular interventions, 2019-04-08 DOI, PubMed 30947938
  • Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial Circulation. Cardiovascular interventions, 2014-06 DOI, PubMed 24803436
  • Ten-year clinical outcomes from a randomized trial comparing new-generation everolimus-eluting stent versus first-generation Sirolimus-eluting stent: Results from the RESET extended study Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2023-10 DOI, PubMed 37545171

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01035450. Randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2014-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial
Acronym
RESET
Intervention (Device)
Everolimus-eluting stent
Intervention (Device)
Sirolimus-eluting stent
Lead sponsor
Takeshi Morimoto (class: other)

Record details

Record id
cardio:ct-nct01035450
Content hash
306fceac8e41aefee2006b253a953bf8a0675306968140c7019bed4e7b0d4a56